As to confirm the oncogenic role of CD229 in vivo, the xenograft mouse model was constructed in the immunodeficient NOD/SCID mice by subcutaneous injection of WT and CD229-OE MM cells into the left and right flank of mice, respectively. The gene discussed is LY9; the disease is Miyoshi myopathy.